Zobrazeno 1 - 10
of 32
pro vyhledávání: '"B, Proy Vega"'
Autor:
M T, Gómez Lluch, B, Proy Vega, M, Cabero Becerra, A, Rodríguez, A, Escalera Zalvide, S A, Sánchez
Publikováno v:
Revista Española de Quimioterapia. 35:260-264
Introduction. Rituximab-induced immunosuppression could be a risk factor for mortality from COVID-19. The aim of the study was to describe the prevalence of SARS-CoV-2 infection in patients who have received rituximab and its association with a persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d172b01e29cc53d8c090258f5e8a611
https://doi.org/10.37201/req/122.2021
https://doi.org/10.37201/req/122.2021
Publikováno v:
Section 2: Selection, procurement and distribution.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93c0c8352c2c15db58bdc7258d84c45f
https://doi.org/10.1136/ejhpharm-2022-eahp.25
https://doi.org/10.1136/ejhpharm-2022-eahp.25
Autor:
MM Alañón Pardo, A Perez Fácila, P. Araque Arroyo, C Notario Dongil, B Proy Vega, JC Valenzuela Gámez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The goal of antiretroviral therapy (ART) is to reduce a person’s viral load to undetectable levels. Poor adherence to ART is the first cause of therapeutic failure in patients infected with HIV. Furthermore, this fact can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::188a10f3abfb0a287cb4149fd19c1e70
https://doi.org/10.1136/ejhpharm-2020-eahpconf.165
https://doi.org/10.1136/ejhpharm-2020-eahpconf.165
Autor:
B Proy Vega
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance HIV is currently one of the more expensive infectious diseases for the health system. Defining efficiency strategies is one way to save costs, in a system where resources are limited. A single tablet regimen (STR) is in some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::984f59e7db30c617dad6f8a7b9fde348
https://doi.org/10.1136/ejhpharm-2020-eahpconf.166
https://doi.org/10.1136/ejhpharm-2020-eahpconf.166
Autor:
JC Valenzuela Gámez, MT Gómez Lluch, MM Alañón Pardo, M.L. Moreno Perulero, MC Conde García, B Proy Vega
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Medication is potentially inappropriate when the risk of adverse effects is greater than the clinical benefit, especially when safer and/or more effective treatments are available. Aim and objectives To analyse potentially i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dec6768572d46a505ac0beb4f14c830
https://doi.org/10.1136/ejhpharm-2020-eahpconf.255
https://doi.org/10.1136/ejhpharm-2020-eahpconf.255
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
JA Garcia Quiñones, JC Valenzuela Gámez, MC Conde García, B Proy Vega, R Carranza González, C Notario Dongil, J. R. Barberá Farré
Publikováno v:
Eur J Hosp Pharm
Background Our antimicrobial stewardship programme was introduced in 2016 in the quality certification system of our hospital and different indicators were designed to evaluate the quality of the process, establishing a limit of acceptability (LA) fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184bf1e16e0843d7dee2f46c569ac8af
https://europepmc.org/articles/PMC7535836/
https://europepmc.org/articles/PMC7535836/
Autor:
MT Gómez Lluch, B Proy Vega, JL Sánchez Serrano, P Nieto-Sandoval Martín de la Sierra, MC Conde García, C Notario Dongil
Publikováno v:
Eur J Hosp Pharm
Background New hepatitis C virus (HCV) antivirals are characterised by their efficacy (achievement of sustained viral response (SVR)) and safety with remarkable adverse drug reactions (ADR), such us hepatic decompensation, hypersensitivity reactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f31a1d3ba167aa5459db166f899fd03
https://doi.org/10.1136/ejhpharm-2018-eahpconf.401
https://doi.org/10.1136/ejhpharm-2018-eahpconf.401
Autor:
B Proy Vega, P. Araque Arroyo, JL Sánchez Serrano, MC Conde García, C Notario Dongil, MT Gómez Lluch
Publikováno v:
Eur J Hosp Pharm
Background Some complications described with enteral nutrition (EN) administration are metabolic and electrolyte disturbances. Purpose To review glycaemic, renal and electrolyte alterations in patients receiving EN as exclusive diet. Material and met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096aa6dbffc6abfc7a7d3d153bd68207
https://doi.org/10.1136/ejhpharm-2018-eahpconf.427
https://doi.org/10.1136/ejhpharm-2018-eahpconf.427
Autor:
M Heredia Benito, JC Valenzuela Gámez, JA Garcia Quiñones, B Proy Vega, MT Gómez Lluch, MC Conde García, JL Sánchez Serrano
Publikováno v:
Clinical pharmacy.
Background Management of catheter related infections (CRIs) depends on the severity, type of catheter and need to keep it. When it is documented, systemic antimicrobial therapy should be started, as antibiotics lock therapy if the central venous cath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca4b9ecf4d0adf62636d921a962cd66b
https://doi.org/10.1136/ejhpharm-2017-000640.57
https://doi.org/10.1136/ejhpharm-2017-000640.57